Berman Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$36K Buy
306
+136
+80% +$15K 0.01% 805
2021
Q2
$16K Buy
170
+116
+215% +$10.3K ﹤0.01% 992
2021
Q1
$4K Buy
54
+48
+800% +$4.46K ﹤0.01% 1365
2020
Q4
$0 Buy
+6
New +$618 ﹤0.01% 1829

Other funds holding TNDM

Berman Capital Advisors's TNDM Position: Q3 2021 in Review

Berman Capital Advisors increased its Tandem Diabetes Care (TNDM) stake by 80% in Q3 2021, buying an estimated $15K and bringing the position to 306 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #805.

Berman Capital Advisors first reported a position in TNDM in Q4 2020 and has held it in 4 quarters since. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

  • Berman Capital Advisors held 306 shares of Tandem Diabetes Care worth $36K as of Q3 2021.
  • Berman Capital Advisors bought 136 Tandem Diabetes Care shares in Q3 2021, an estimated $15K.
  • Tandem Diabetes Care made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #805 holding.
  • Berman Capital Advisors first reported a position in Tandem Diabetes Care in Q4 2020 and has held it in 4 quarters since.
  • 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.